{"id":"W2029406607","doi":"10.1161/01.str.0000258004.64840.0b","title":"Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation","year":2007,"lang":"en","type":"article","venue":"Stroke","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"AstraZeneca","keywords":"Ximelagatran; Medicine; Warfarin; Stroke (engine); Aspirin; Atrial fibrillation; Internal medicine; Cardiology; Anesthesia; Direct thrombin inhibitor; Dabigatran","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002539098,0.0001623478,0.0002600026,0.0002430835,0.00005583967,0.00002060666,0.00004199613,0.00008503538,0.0001717491],"category_scores_gemma":[0.00003122884,0.0001252163,0.0001141647,0.0002212213,0.00003718509,0.0002145642,0.00002095465,0.0001443572,0.00002235406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001084754,"about_ca_system_score_gemma":0.00006757803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003527305,"about_ca_topic_score_gemma":0.0003548134,"domain_scores_codex":[0.9987049,0.00002645329,0.0003087674,0.0002505505,0.000437386,0.0002719987],"domain_scores_gemma":[0.9994344,0.00008078377,0.0001332702,0.0001934038,0.00007265688,0.00008547671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01565471,0.000007663096,0.9523535,0.00002778651,0.0001404881,0.000007014723,0.00007407578,0.0001762153,0.00004126757,0.000152603,0.00003070585,0.03133402],"study_design_scores_gemma":[0.02427778,0.001814984,0.9675075,0.00004668431,0.0001683724,7.91858e-7,0.0001231031,0.00003602516,0.0002329911,0.00001300402,0.005622319,0.0001564195],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893497,0.00004249334,0.0007507329,0.0001785527,0.0003079947,0.0008596248,0.00001541358,0.00006038678,0.008435071],"genre_scores_gemma":[0.9933209,0.000005369916,0.001693849,0.00001465457,0.0007582178,4.204938e-7,0.0001712664,0.00002377482,0.00401155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0311776,"threshold_uncertainty_score":0.5106171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02702543449025141,"score_gpt":0.2967043324481454,"score_spread":0.269678897957894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}